Krystal Biotech, Inc. KRYS Operating Lease Weighted Average Discount Rate Percent
Operating Lease Weighted Average Discount Rate Percent at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s operating lease weighted average discount rate percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s operating lease weighted average discount rate percent?
- Krystal Biotech, Inc. (KRYS) reported operating lease weighted average discount rate percent of $0.1 in Q1 2026.
- How has Krystal Biotech, Inc.'s operating lease weighted average discount rate percent changed year-over-year?
- Krystal Biotech, Inc.'s operating lease weighted average discount rate percent increased by 1.0% year-over-year, from $0.1 to $0.1.
- What is the long-term trend for Krystal Biotech, Inc.'s operating lease weighted average discount rate percent?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s operating lease weighted average discount rate percent has grown at a 0.6% compound annual growth rate (CAGR), from $0.09 to $0.1.